Top 10 Companies in the Biodegradable Nanoparticles Market (2026): Market Leaders Powering Global Growth

In Business Insights
October 02, 2026


MARKET INTELLIGENCE OVERVIEW

Biodegradable Nanoparticles Market Insights

Global biodegradable nanoparticles market was valued at USD 3,050 million in 2025. The market is projected to grow from USD 3,600 million in 2026 to USD 7,500 million by 2034, exhibiting a CAGR of 10.5% during the forecast period. Biodegradable nanoparticles are engineered, eco‑friendly particles designed to break down safely after delivering active agents, finding applications in drug delivery, agricultural formulations, cosmetics, and environmental remediation.

📊
Current Market Size
3,050
USD Mn

2025 Value

📈
CAGR
10.5%

2026–2034

🎯
Forecast Market Size
7,500
USD Mn

By 2034

Strategic Market Outlook
Long-Term Industry Perspective
Biodegradable nanoparticles are expected to gain further traction as regulatory pressures favor sustainable materials and as innovations in polymer science improve performance across pharmaceutical, agricultural, and cosmetic sectors.

🌐
Leading Region
North America

🌍
Emerging Region
Asia‑Pacific



Biodegradable Nanoparticles Market – View in Detailed Research Report

Biodegradable nanoparticles (BNPs) are engineered, eco‑friendly particles designed to break down safely after delivering active agents, enabling controlled release and reducing environmental footprint across drug delivery, agriculture, cosmetics, and remediation.

1️⃣ 1. BASF (Germany)

Headquarters: Ludwigshafen, Germany
Key Offering: PLGA‑based nanocarriers for drug delivery and agriculture

BASF’s extensive PLGA portfolio supports a wide range of therapeutic and agrochemical applications, with a global production network that ensures rapid scale‑up and consistent particle quality.

Sustainability & Growth Initiatives:

  • Investment in green polymer chemistry to lower carbon footprint.
  • Partnerships with pharma and agri‑tech firms to expand market reach.
  • Commitment to circular manufacturing and waste reduction.

2️⃣ 2. Evonik Industries (Germany)

Headquarters: Essen, Germany
Key Offering: Custom biodegradable polymer resins and nanoparticle services

Evonik delivers tailored polymer solutions that integrate seamlessly into large‑volume drug delivery pipelines, emphasizing safety and regulatory readiness.

Sustainability & Growth Initiatives:

  • Development of low‑toxicity polymer blends.
  • Collaboration with research institutes for next‑generation carriers.
  • Adoption of closed‑loop production processes.

3️⃣ 3. NanoComposix (USA)

Headquarters: West Lafayette, Indiana, USA
Key Offering: Silica‑coated PLGA nanoparticles for clinical trials

NanoComposix’s precision engineering delivers uniform particle size, critical for reproducible therapeutic outcomes.

Sustainability & Growth Initiatives:

  • Use of renewable feedstocks for polymer synthesis.
  • Partnerships with medical device manufacturers.
  • Investment in scalable manufacturing platforms.

4️⃣ 4. PolySciTech (USA)

Headquarters: Santa Ana, California, USA
Key Offering: Ready‑to‑use PLGA formulations and surface functionalization

PolySciTech offers turnkey solutions that accelerate time‑to‑market for biotech startups.

Sustainability & Growth Initiatives:

  • Development of biodegradable excipients.
  • Integration of digital analytics for process optimization.
  • Strategic alliances with academic research centers.

5️⃣ 5. Cospheric (France)

Headquarters: Paris, France
Key Offering: Customized PLGA nanoparticles for cosmetics and therapeutics

Cospheric’s platform supports both cosmetic and pharmaceutical applications, emphasizing skin‑friendly profiles.

Sustainability & Growth Initiatives:

  • Use of bio‑derived polymers.
  • Collaboration with beauty brands to develop green formulations.
  • Adoption of eco‑friendly packaging solutions.

6️⃣ 6. Nanobiotix (France)

Headquarters: Paris, France
Key Offering: Hafnium oxide nanoparticles for radiotherapy enhancement

Nanobiotix pioneers inorganic biodegradable carriers that combine therapeutic efficacy with safety.

Sustainability & Growth Initiatives:

  • Research into biodegradable inorganic materials.
  • Partnerships with oncology research groups.
  • Focus on regulatory compliance for medical devices.

7️⃣ 7. Akari Therapeutics (USA)

Headquarters: New York, New York, USA
Key Offering: Injectable PLGA‑based vaccine delivery platforms

Akari’s platforms respond to emerging infectious disease needs, delivering vaccines with controlled release.

Sustainability & Growth Initiatives:

  • Use of biodegradable polymers in vaccine carriers.
  • Collaboration with global health organizations.
  • Investment in scalable biomanufacturing.

8️⃣ 8. Bayer (Germany)

Headquarters: Leverkusen, Germany
Key Offering: Biodegradable nanoparticle formulations for agrochemicals

Bayer integrates BNPs into its crop protection portfolio, enhancing efficacy while reducing environmental persistence.

Sustainability & Growth Initiatives:

  • Development of low‑impact delivery systems.
  • Partnerships with agricultural universities.
  • Commitment to sustainable farming practices.

9️⃣ 9. Johnson & Johnson (USA)

Headquarters: New Brunswick, New Jersey, USA
Key Offering: Biodegradable nanoparticle‑based drug delivery for chronic conditions

Johnson & Johnson leverages BNPs to improve drug bioavailability and patient adherence.

Sustainability & Growth Initiatives:

  • Investment in green pharmaceutical manufacturing.
  • Collaboration with biotech firms for advanced delivery.
  • Focus on reducing waste in drug production.

🔟 10. Pfizer (USA)

Headquarters: New York, New York, USA
Key Offering: Nanoparticle‑enhanced vaccine platforms

Pfizer’s BNPs contribute to robust vaccine performance and stability.

Sustainability & Growth Initiatives:

  • Use of biodegradable excipients in vaccines.
  • Partnerships with global health agencies.
  • Investment in sustainable supply chains.



Download FREE Sample Report



Get Full Report

Future Trends Shaping the Market

  • Integration of smart, stimuli‑responsive carriers that activate under specific physiological conditions.
  • Expansion of BNPs into precision agriculture, offering controlled release of nutrients and pesticides.
  • Growth of digital health platforms that monitor nanoparticle delivery in real time.
  • Continued focus on cost reduction through scalable manufacturing and raw‑material sourcing.

Strategic Outlook for 2026‑2034

The biodegradable nanoparticles market will continue to be shaped by regulatory momentum and innovation in polymer science. Companies that align their R&D with sustainability goals and invest in scalable production are positioned to capture the expanding demand across pharmaceutical, agricultural, and cosmetic sectors.